Month: September 2021
-
Delivery Tech Licensed for CBD Epilepsy Nasal Spray
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain.
-
Infographic – Digital Therapeutics Funding on the Rise
The technology intelligence company CB Insights reported on new investments in digital therapeutics and found a record-setting funding pace this year.
-
Neuroscience Software Company Raises $23M in Early Funds
A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round.
-
Yom Kippur 5782
Regular posting will resume tomorrow, Friday, 17 Sept.
-
FDA Okays One-Time HIV Treatment Clinical Trial
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial.
-
Trial Shows VR Training Helps Correct Lazy Eye in Kids
Clinical trial findings show a digital therapy using virtual reality headsets improves vision in children with amblyopia, or lazy eye, more than corrective lenses alone.
-
Gene-Edited Treatments in Works for Safer Cancer Therapies
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies.
-
Infographic – US Employer Vaccine Mandates Tick Up
A new poll shows a jump in the percentage of American workers now required by employers to get vaccinated against Covid-19.
-
Essential Skills For Starting A Business
By being equipped with the right skills, the chance of your business succeeding is a lot greater than if you just try and wing it as you go along.
-
Pharma, Synthetic Bio Companies to Find Antibody Therapies
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases.